<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00810037910438</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName>OraCoat XyliMelts</deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA91043</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-03T12:30:37.891Z</lastUpdated>
  </row>
  <row>
    <udiDi>01230000169011</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>01230000169011</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>01230000169011</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-24T02:35:00.000Z</lastUpdated>
  </row>
  <row>
    <udiDi>01230000169028</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>01230000169028</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1230000169028</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-24T02:34:59.987Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000210</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00210</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.953Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000555</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00361</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.936Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000746</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00354</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000777</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts - DACH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00777</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.905Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000814</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00814</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.886Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000821</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00821</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.865Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-XyliMelts6E</udiDi>
    <basicUdiDi>B-XyliMelts6E</basicUdiDi>
    <tradeName>D-XyliMelts6E</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>XyliMelts</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:52:15.099Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910889</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:53.951Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910872</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:52.854Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910834</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:51.750Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910827</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:50.649Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910810</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:49.517Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910803</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:48.417Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910797</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:47.314Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910452</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:46.190Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810037910445</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T20:52:45.084Z</lastUpdated>
  </row>
</eudamedExport>